Cervical Cancer
Conditions
Keywords
Cervical Cancer
Brief summary
The percentages of participants in clinical studies haven't always been perfectly representative of a particular group. This research examines the variables that affect a patient's choice to enroll in, discontinue participation in, or resume participation in a clinical trial for cervical cancer. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future cervical cancer studies.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Aged ≥ 18 years old * Ability to understand and the willingness to sign a written informed consent document. * Willing and able to comply with scheduled visits, treatment schedule, laboratory tests and other requirements of the study.
Exclusion criteria
* Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study * Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial * Patients with any significant history of non-compliance to medical regimens or with inability to grant a reliable informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of patients who decide to enroll in a cervical cancer clinical study. | 3 months |
| Number of cervical cancer study participants who remain in clinical trial until completion. | 12 months |
Contacts
Primary ContactMichael B Gill
Outcome results
None listed